19
Inventia Healthcare Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Your preferred development and manufacturing partner for any market.
One of their notable products is PALIPERIDONE, with a corresponding application number 204452.
Regulatory Information RX
With a dosage strength 9MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2019-06-12
Therapeutic Equivalence (TE) Code AB
18
Inventia Healthcare Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Your preferred development and manufacturing partner for any market.
One of their notable products is PALIPERIDONE, with a corresponding application number 204452.
Regulatory Information RX
With a dosage strength 3MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2019-06-12
Therapeutic Equivalence (TE) Code AB
17
Inventia Healthcare Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Your preferred development and manufacturing partner for any market.
One of their notable products is PALIPERIDONE, with a corresponding application number 204452.
Regulatory Information RX
With a dosage strength 6MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2019-06-12
Therapeutic Equivalence (TE) Code AB
16
Inventia Healthcare Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Your preferred development and manufacturing partner for any market.
One of their notable products is PALIPERIDONE, with a corresponding application number 204452.
Regulatory Information RX
With a dosage strength 1.5MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2019-06-12
Therapeutic Equivalence (TE) Code AB